Last update :
19/11/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Antiemetic   Rolapitant  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Varubi United States of America
Stability of mixtures   injection   Stability of mixtures : Rolapitant     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass None 1,65 mg/ml
injection   Rolapitant   
injection   Palonosetron hydrochloride 2,28 µg/ml
2-8°C
7 Day
Protect from light 3928
Level of evidence A+
Glass None 1,83 mg/ml
injection   Rolapitant   
injection   Granisetron hydrochloride 0,01 mg/ml
2-8°C
48 Hour
Protect from light 4061
Level of evidence C+
Glass None 1,6 mg/ml
injection   Rolapitant   
injection   Palonosetron hydrochloride 2,1 µg/ml
injection   Dexamethasone sodium phosphate 0,178 mg/ml
2-8°C
48 Hour
Protect from light 4062
Level of evidence C+
Glass None 1,6 mg/ml
injection   Rolapitant   
injection   Palonosetron hydrochloride 2,1 µg/ml
injection   Dexamethasone sodium phosphate 0,093 mg/ml
2-8°C
48 Hour
Protect from light 4062
Level of evidence C+
Glass None 1,65 mg/ml
injection   Rolapitant   
injection   Palonosetron hydrochloride 2,28 µg/ml
20-25°C
2 Day
Protect from light 3928
Level of evidence A+
Glass None 1,7 mg/ml
injection   Rolapitant   
injection   Dexamethasone sodium phosphate 0,086 mg/ml
20-25°C
6 Hour
Light 3927
Level of evidence A+
Glass None 1,7 mg/ml
injection   Rolapitant   
injection   Dexamethasone sodium phosphate 0,170 mg/ml
20-25°C
6 Hour
Light 3927
Level of evidence A+
Glass None 1,83 mg/ml
injection   Rolapitant   
injection   Granisetron hydrochloride 0,01 mg/ml
20-25°C
24 Hour
Light 4061
Level of evidence C+
Glass None 1,6 mg/ml
injection   Rolapitant   
injection   Palonosetron hydrochloride 2,1 µg/ml
injection   Dexamethasone sodium phosphate 0,093 mg/ml
20-25°C
24 Hour
Light 4062
Level of evidence C+
Glass None 1,6 mg/ml
injection   Rolapitant   
injection   Palonosetron hydrochloride 2,1 µg/ml
injection   Dexamethasone sodium phosphate 0,178 mg/ml
20-25°C
24 Hour
Light 4062
Level of evidence C+
Cristal Zenith® None 1,65 mg/ml
injection   Rolapitant   
injection   Palonosetron hydrochloride 2,28 µg/ml
2-8°C
7 Day
Protect from light 3928
Level of evidence A+
Cristal Zenith® None 1,65 mg/ml
injection   Rolapitant   
injection   Palonosetron hydrochloride 2,28 µg/ml
20-25°C
2 Day
Protect from light 3928
Level of evidence A+
Cristal Zenith® None 1,7 mg/ml
injection   Rolapitant   
injection   Dexamethasone sodium phosphate 0,170 mg/ml
20-25°C
6 Hour
Light 3927
Level of evidence A+
Cristal Zenith® None 1,7 mg/ml
injection   Rolapitant   
injection   Dexamethasone sodium phosphate 0,086 mg/ml
20-25°C
6 Hour
Light 3927
Level of evidence A+
  Mentions Légales